Skip to main content
BCYC logo
BCYC
(NASDAQ)
Bicycle Therapeutics plc
$4.37-- (--)
Loading... - Market loading

Bicycle Therapeutics (BCYC) Stock Price & Financial Analysis

Bicycle Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.25 - $4.51
52-Week High$9.16
52-Week Low$3.75
Open$4.29
Volume480.74K
Average Volume (3M)327.56K
Market Cap288.99M
Shares Outstanding69.80M
Price to Sales (P/S)4.56
Price to Book (P/B)0.55
EV/EBITDA1.15
Revenue (TTM)61.20M
Net Income (TTM)-190.41M
Free Cash Flow (TTM)-205.84M
EPS (TTM)$-2.74
Profit Margin-311.11%
Operating Margin-343.95%
Return on Equity (ROE)-37.32%
Debt to Equity0.03
50-Day MA$4.09
200-Day MA$5.36
52-Week Change-46.95%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Bicycle Therapeutics

What is the current stock price for BCYC?

As of the latest trading session, BCYC stock trades at $4.37. The 52-week range is $3.75–$9.16, with a day range of $4.25–$4.51.

What is the P/E ratio for BCYC?

The P/E ratio (Price-to-Earnings) for BCYC is shown in the Key Statistics section. This valuation metric helps compare Bicycle Therapeutics plc to industry peers.

Does BCYC pay dividends?

Bicycle Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BCYC?

Based on 1 analyst, the consensus for BCYC is Buy.

What is the market cap of BCYC?

Bicycle Therapeutics's market capitalization is $305.0M, classifying it as a small-cap company. Bicycle Therapeutics operates in the Healthcare sector within the Biotechnology industry.